Highlights
NASDAQ: DCPH       Deciphera Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
69.40   +2.23 (3.32%)  66.90 - 69.88  438,800

Overview

 
Avg Volume (4 weeks):540,127
4 Weeks Range:55.40 - 69.88
4 Weeks Price Volatility (%):
96.69%
52 Weeks Range:19.88 - 70.00
52 Weeks Price Volatility (%):
98.80%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Deciphera Pharmaceuticals Inc is a biotechnology company, develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations are functioned through the region of US.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers